Pfizer and BioNTech announced on Tuesday that they have begun a clinical trial to evaluate a new, omicron-specific vaccine for COVID-19. People who are vaccinated and boosted appear to be better protected against severe disease and hospitalization from omicron, but the highly contagious variant has still led to breakthrough cases and a surge in overall infections. Kathrin U. Jansen, Pfizer's senior vice president and head of vaccine research and development, said in a statement: "While current research and real-world data show that boosters continue to provide a high level of protection against severe disease and hospitalization with Omicron, we recognize the need to be prepared in the event this protection wanes over time and to potentially help address Omicron and new variants in the future." The study will include over 1,000 participants divided into three groups One group includes people who have already received two doses of the current Pfizer-BioNTech vaccine and
ODD DIMENSION for the release of their new opus ‘The Blue Dawn’.
This is how the band commented: “Ladies and gentlemen, we are finally back in the saddle, relying on the commitment of our longtime members Gianmaria Saddi (guitars), Gigi Andreone (bass) and Gabriele Ciaccia (keyboards), who have been joined in the last two years by Gianbattista “Jan” Manenti (vocals, The UNITY) and Marco Lazzarini (drums, Secret Sphere and Archon Angel). The follow-up to our latest full-length ‘The Last Embrace to Humanity’ is a concept-album that perfectly captures the band’s trademark breadth of melodic, modern and progressive metal. We can’t wait to share all the details with you!”